Humana’s Medicare Advantage dilemma worsens amid precipitous drop in 2025 star ratings
Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer ...
Humana’s stock extends losses as BofA downgrades to sell on concerns about margin recovery
Humana Inc.’s stock closed down another 1.9% on Thursday to bring its week-to-date losses to 24.3%, after BofA Securities ...
These Stocks Are Moving the Most Today: EVgo, Levi Strauss, Humana, Hims & Hers, Nvidia ...
EVgo stock surges after the company receives a $1 billion Energy Department loan commitment, Levi Strauss tumbles after ...
Watch These Humana Price Levels as Stock Plummets on Medicare Plan Ratings Downgrade
Shares in Humana will likely remain on watchlists after plunging 12% Wednesday on news the Centers for Medicare and Medicaid ...
Quality ratings hit to key Medicare plan shakes Humana stock
Shares of Humana have tumbled after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus ...
Humana Shares Plunge After Changes in Medicare Star Ratings
The stock slid more than 10% as the health insurer warned that a steep drop in the federal government’s quality ratings of ...
Humana's stock extends losses as BofA downgrades to sell on concerns about a margin recovery
Humana Inc.'s stock slid another 2.5% Thursday to bring its week-to-date losses to 24.4%, after BofA Securities downgraded it to underperform - or sell - on concerns about a delay in margin recovery.
Heard on the Street Wednesday Recap: The Humana Condition
Between the escalating conflict in the Middle East and the lead up to the U.S. presidential election, investors have had a ...
Humana’s Star Rating Decline Prompts Hold Rating Amid Financial Uncertainty
Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...
Humana股票面临29亿美元收入风险，源于Medicare变化，富国银行称
在其他近期新闻中，Humana Inc.出现了重大发展。根据伯恩斯坦的分析，该健康保险公司2025年的Medicare Advantage产品因定价策略问题引发市场担忧。此外，Humana的Medicare星级评级出现戏剧性下降，4星以上计划的成员比例从94%降至仅25%。这主要归因于Humana的H5216合同（约占Humana Medicare ...
Humana stock takes big hit; Medicare ratings drop could cost company $1.9 billion
The insurer said the share of its customers currently enrolled in plans rated four stars or higher for 2025 is down to 25% ...
Humana股票保持稳定，分析师重申"市场表现"评级
周四，尽管面临美国医疗保险和医疗补助服务中心（CMS）对其计划评级的挑战，Raymond James仍维持Humana Inc.（NYSE:HUM）股票的"市场表现"评级。该公司股价在初始下跌后略有回升，交易价格为247美元，较近期高点大幅下跌。 Humana的管理层召开电话会议，讨论了他们正在进行的对CMS上诉可能产生的影响。此次上诉旨在解决Medicare Advantage（MA）计划评级中 ...